Filter:AllMonitoringDiagnosisComplicationsType 1Type 2
GLP-1 Medications and Heart Protection: What the Evidence Shows: cardiovascular outcome trial evidence, who benefits most, and how this drug class fits into.
Muscle Loss on GLP-1 Medications: How to Preserve Lean Mass: how it works, who it’s used for, common side effects, and current NICE NG28 guidance.
Retatrutide: A New Horizon in Diabetes and Obesity Management: evidence-based guidance reviewed against current NICE and ADA recommendations. Practical.
Tirzepatide (Mounjaro): A Complete Guide: how it works, who it’s used for, common side effects, and current NICE NG28 guidance. Evidence-based guide from.
Managing GLP-1 Side Effects: A Practical Guide: practical strategies for managing common side effects, when to call your team, and how to stay on track.
What to Expect in Your First Month on Semaglutide: how it works, who it’s used for, common side effects, and current NICE NG28 guidance. Evidence-based guide.
Ozempic vs Wegovy vs Mounjaro: Complete Comparison: how it works, who it’s used for, common side effects, and current NICE NG28 guidance. Evidence-based.
Is Type 2 Diabetes a Life Sentence? A New Hope for Reversal: type 2 diabetes guidance under NICE NG28 — what the evidence shows, what to expect, and how it.
HIIT for Diabetes: Short Bursts, Big Changes in Health: evidence-based guidance reviewed against current NICE and ADA recommendations. Practical.
How Obesity Is Becoming a Bigger Problem for Young Adults — What Might Happen by 2050: evidence-based guidance reviewed against current NICE and ADA.
